Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: A multi-institutional cohort study
2023 · Journal of the American Academy of Dermatology · 68 citations
https://doi.org/10.1016/j.jaad.2022.12.048